24150	||||	20389	||||	17922	||||	DISCHARGE_SUMMARY	||||	2016-08-07 00:00:00.0	||||		||||		||||		||||	
Admission Date:  [**2016-08-02**]              Discharge Date:   [**2016-08-07**]

Date of Birth:  [**1942-11-18**]             Sex:   M

Service: MEDICINE

Allergies: 
Penicillins

Attending:[**Attending Info 1593**] 
Chief Complaint:
x-fer for cath

Major Surgical or Invasive Procedure:
CARDIAC CATHETERIZATION: SEVERE 3VD; NOT AMENDABEL TO 
PERCUTANEOUS INTERVENTION

EGD: [**Female First Name (un) **] ESOPHAGITIS; GASTRIC ULCERS

History of Present Illness:
73 yo male with no known cad, but multiple risk factors including htn, hyperlipidemia, NIDDM and smoking, has been experiencing incteasing DOE. was admitted to osh on [**2016-07-30**], where he undewent elective radical prostatectomy, post-operatively, developed n/v/diaphoresis and ruled in for inferior STEMI with peak CK of 770 and TrI of 29 on [**07-31**]--> was transferred to ICU (OSH) for close monitoring, where he develped afib with RVR, experienced episode of hypotension after IV lopressor and was subsequently transferred to BODMC for further management on heparin gtt; dilt gtt, and asa. Upon arrival to [**Hospital1 18**] CCU, pt was in NSR and was sx-free. Pt denies h/o prior AF. He never had a prior cardiac evaluation.

Past Medical History:
HTN
Hyperchol
NIDDM
Prostate ca-> s/p radical prostatectomy
Gout

Social History:
retired; long standing h/o tobacco use (quit 3 mos ago); last drink 3 mos ago

Family History:
n/c

Physical Exam:
HR 65  100/60

NAD
no JVD; no bruits
CTA B
RRR; S1/2; no m/r/g
obese abd; positive BS
no c/c/e; peripheral pulses intact by Doppler

Pertinent Results:
[**2016-08-02**] 10:39AM   PT-14.0* PTT-52.4* INR(PT)-1.3
[**2016-08-02**] 10:39AM   PLT COUNT-250
[**2016-08-02**] 10:39AM   WBC-13.8* RBC-3.39* HGB-10.6* HCT-30.5*  MCV-90 MCH-31.2 MCHC-34.8 RDW-13.4
[**2016-08-02**] 10:39AM   TRIGLYCER-119 HDL CHOL-43 CHOL/HDL-3.7  LDL(CALC)-94
[**2016-08-02**] 10:39AM   CALCIUM-9.1 PHOSPHATE-2.2* MAGNESIUM-2.1  CHOLEST-161
[**2016-08-02**] 10:39AM   CK-MB-11* MB INDX-5.3 cTropnT-2.43*
[**2016-08-02**] 10:39AM   CK(CPK)-208* TOT BILI-0.8
[**2016-08-02**] 10:39AM   GLUCOSE-232* UREA N-27* CREAT-1.6* SODIUM-135  POTASSIUM-3.5 CHLORIDE-101 TOTAL CO2-25 ANION GAP-13
[**2016-08-02**] 03:00PM   PT-13.8* INR(PT)-1.3
[**2016-08-02**] 03:00PM   ALT(SGPT)-19 AST(SGOT)-31 CK(CPK)-154 ALK  PHOS-58 AMYLASE-14 TOT BILI-0.9

Brief Hospital Course:
73 yo male with multiple cardiac risk factors; s/o inferior STEMI at OSH and one episode of rapid afib.

1. s/p inferior STEMI: sx free upom arrival on asa, integrillin, heparin gtt. Started lipitor, cont lopressor. cardiac cath revealed 3VD: 80% prox LAD and 70% mid LAD; 50 % diffuse OM1 and 70% OM2; cronically occluded RCA with TIMI 1 flow via L-R collaterals. C-[**Hospital Unit Name **] consult was obtained for evaluation for CABG. However, pt had an episode of melena and EGD revelaed severe [**Female First Name (un) **] esophagitis and esoph ulcers; it was felt that pt is at high [**Hospital Unit Name **] risk and CABG was postponed with outpt followed up after appropriate H. pylori therapy.

2. Pump: TTE revealed EF 20-25%; 2+ MR [**First Name (Titles) **] [**Last Name (Titles) 4276**] pulm HTN. ACE-I was started and tolerated well by pt. It was decided to place Swan-[**Doctor Last Name 4277**] catheter for tailored diuresis prior to anticipated CABG later on same week. S-G catheter was successfully placed with initial [**Location (un) 1157**] of PA 45/19 (28); PCWP 26; CI 4.5; CO 21.; SVR 1262; MVO2 57%, with improvement after diuresis. Pt toleareted lopressor and ACE-I. 

3. Rhythm: AFIB: several episodes of AFIB while in the hospital. Amio po load; heparin gtt for anticoagulation

4. GIB: pt had an episode of melena. Hct was checked and was stable at 29, iron studies were c/w mixed iron deficiency anemia and AOCD. it was decided to proceed with EGD to r/o significant UGIB prior to planed CABG. EGD showed severe [**Female First Name (un) **] esophagitis and multiple ulcers. It was felt that pt would be at a high risk for CABG and [**Hospital Unit Name **] was postponed. Fluconazole was started as well as H/ pyloru therapy
5. UTI: treated with Ciprofolacin without complications

6. DM: oral hypoglycemics in addition to insulin sliding scale. diabetic education provided to pt and his wife with [**Name2 (NI) 4278**] on importance of toght glycemic control. toleratig glargine.

Medications on Admission:
lipitor 
paxil

Discharge Medications:
1. Aspirin 325 mg Tablet, Delayed Release (E.C.) Sig: One (1) Tablet, Delayed Release (E.C.) PO QD (once a day). Disp:*30 Tablet, Delayed Release (E.C.)(s)* Refills:*2*
2. Atorvastatin Calcium 40 mg Tablet Sig: One (1) Tablet PO QD (once a day). Disp:*30 Tablet(s)* Refills:*2*
3. Fluconazole 100 mg Tablet Sig: One (1) Tablet PO Q24H (every 24 hours) for 11 days. Disp:*21 Tablet(s)* Refills:*0*
4. Lisinopril 10 mg Tablet Sig: One (1) Tablet PO QD (once a day). Disp:*30 Tablet(s)* Refills:*2*
5. Imdur 30 mg Tablet Sustained Release 24HR Sig: One (1) Tablet Sustained Release 24HR PO once a day. Disp:*30 Tablet Sustained Release 24HR(s)* Refills:*2*
6. Glimepiride 2 mg Tablet Sig: One (1) Tablet PO twice a day. Disp:*60 Tablet(s)* Refills:*2*
7. Clarithromycin 500 mg Tablet Sig: One (1) Tablet PO BID (2 times a day) for 11 days: Take through [**08-17**], to complete your 2-week course. Disp:*21 Tablet(s)* Refills:*0*
8. Colchicine 0.6 mg Tablet Sig: One (1) Tablet PO QD (once a day) for 3 days. Disp:*3 Tablet(s)* Refills:*0*
9. Amiodarone HCl 200 mg Tablet Sig: One (1) Tablet PO As directed.: Take Every 12 hours through [**08-10**].  Then take once daily thereafter.  . Disp:*60 Tablet(s)* Refills:*2*
10. Multivitamin     Capsule Sig: One (1) Cap PO QD (once a day). Disp:*30 Cap(s)* Refills:*2*
11. Amoxicillin 500 mg Capsule Sig: One (1) Capsule PO Q12H (every 12 hours) for 11 days: Take through [**08-17**]. Disp:*21 Capsule(s)* Refills:*0*
12. Metoprolol Succinate 100 mg Tablet Sustained Release 24HR Sig: One (1) Tablet Sustained Release 24HR PO QD (once a day). Disp:*30 Tablet Sustained Release 24HR(s)* Refills:*2*
13. Pantoprazole Sodium 40 mg Tablet, Delayed Release (E.C.) Sig: One (1) Tablet, Delayed Release (E.C.) PO Q12H (every 12 hours): Take Twice daily through [**08-17**], then take once daily. Disp:*60 Tablet, Delayed Release (E.C.)(s)* Refills:*2*
14. Nitroglycerin 0.3 mg Tablet, Sublingual Sig: One (1)  
Sublingual PRN as needed for chest pain: Take for episodes of chest pain.  COntact your PCP or go to [**Doctor First Name 5**] if your pain is not relieved by 2-3 tabs.
Disp:*30 pills* Refills:*2*

Discharge Disposition:
Home with Service

Discharge Diagnosis:
1. INFERIOR STEMI
2. CAD: 3 VESSEL DISEASE
3. [**Female First Name (un) **] ESOPHAGITIS
4. GIB: GASTRIC ULCERS
5. DIABETES, Type II
6. Chronic renal insufficiency
7. S/P PROSTATECTOMY
8. paroxysmal atrial fibrillation

Discharge Condition:
STABLE

Discharge Instructions:
1. PLEASE TAKE ALL OF YOUR MEDICATIONS AS DIRECTED.  You have several new medications.
2. PLEASE Return to the EMERGENCY ROOM IF you EXPERINCE any CHEST PRESSURE OR TIGHTNESS, CHEST PAIN OR SHORTNESS OF BREATH, ESPECIALLY if your symptoms are not relieved by rest.

Followup Instructions:
1. PLEASE FOLLOW UP WITH YOUR PRIMARY CARE PHYSICIAN [**Name9 (PRE) **] 1 WEEK.  -You should have your kidney function (creatinine) and blood count (hematocrit) checked within one week, and again within one month, along with liver and muscle tests (as you have been started on a higher dose of Lipitor). -You should also discuss referral for a repeat endosocopy (EGD) one month from hospital discharge (prior to your bypass surgery, as per Dr. [**Last Name (STitle) 272**]).   -Discuss also having an outpatint colonoscopy with your primary care physician following BYPASS SURGERY.   -In addition, since you have been started on a new medication called amiodarone (to control your heart rate/arrhythmia), you will need to have pulmonary function tests and thyroid tests within the next month (your PCP can give you a referral for this). -Discuss also referral for diabetic education on lifestyle modification.
2. PLEASE FOLLOW UP WITH Dr. [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) 272**] in 4-6 WEEKS.  Please phone to schedule appointment: [**Telephone/Fax (2) 1030**]. 3. Please follow-up with your urologist within one week.  Please phone to schedule your appointment.
4. Please also schedule a follow-up appointment with Dr. [**First Name4 (NamePattern1) **] [**Last Name (NamePattern1) 223**] for an electrophysiology consultation (following your bypass surgery).  His office phone number is [**Telephone/Fax (2) 487**].  

[**First Name11 (Name Pattern1) **] [**Name7 (MD) **] MD [**MD Number 1596**]

Completed by: [**Name6 (MD) 1597**] GOLDMAN MD [**MD Number 1598**] [**2016-12-23**] @ 1636
Signed electronically by: DR. [**First Name4 (NamePattern1) **] [**Last Name (NamePattern1) **] on: TUE [**2016-12-27**] 5:21 PM
(End of Report)

